Table 1 Overview of treatments administered to the different experimental groups
From: Liposomal doxorubicin improves radiotherapy response in hypoxic prostate cancer xenografts
Experimental groups | Treatment |
|---|---|
Control | No treatment |
PL-DXR | 3.5 mg DXR/kg (day 0) |
PL-DXR + hypoxic RT | 3.5 mg DXR/kg (day 0) + clamping + 2 Gy/day for 5 days (day 1 - day 5) |
RT | 2 Gy/day for 5 days (day 1 - day 5) |
Hypoxic RT | Clamping + 2 Gy/day for 5 days (day 1 - day 5) |